Ono Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Ono Pharmaceutical has a total shareholder equity of ¥790.7B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥891.7B and ¥101.0B respectively. Ono Pharmaceutical's EBIT is ¥172.1B making its interest coverage ratio -53.9. It has cash and short-term investments of ¥135.6B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -53.9x |
Cash | JP¥135.56b |
Equity | JP¥790.68b |
Total liabilities | JP¥101.05b |
Total assets | JP¥891.73b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OPHL.F's short term assets (¥354.3B) exceed its short term liabilities (¥89.7B).
Long Term Liabilities: OPHL.F's short term assets (¥354.3B) exceed its long term liabilities (¥11.3B).
Debt to Equity History and Analysis
Debt Level: OPHL.F is debt free.
Reducing Debt: OPHL.F has no debt compared to 5 years ago when its debt to equity ratio was 0.4%.
Debt Coverage: OPHL.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: OPHL.F has no debt, therefore coverage of interest payments is not a concern.